Imuno Brasil

What Imuno Brasil does

Imuno Brasil is a Brazilian privately held medical group headquartered in São Paulo that provides multidisciplinary clinical care for patients with immune-mediated diseases across five specialties: rheumatology, neurology, gastroenterology, dermatology, and immunology. The company operates through a network of 150+ specialist physicians working out of 33+ service locations in 5 Brazilian states, including 16 hospital partnerships with centers of excellence such as Hospital Santa Paula, Hospital Santa Catarina, Hospital Vitória, Hospital Assunção, and Leforte Morumbi. Patient volume exceeds 30,000 visits per month, and revenue is generated through professional medical services billed within Brazil's supplementary health system and private-pay arrangements. Pricing is not publicly disclosed.

The group originated from Cobra Reumatologia, an 80-year family rheumatology practice, and was reorganized and rebranded as Imuno Brasil in 2023 to reflect its broader multi-specialty scope and multi-state presence. Beyond clinical care, Imuno Brasil maintains an academic-clinical ecosystem anchored by research collaborations with the Department of Rheumatology and Immunology at the University of Erlangen-Nuremberg (Germany) and the McCaig Institute for Bone and Joint Health at the University of Calgary, producing peer-reviewed publications on topics including COVID-19 vaccine perceptions in immune-mediated disease patients and psoriatic arthritis serology. The company is led by founder Dr. Jayme Fogagnolo Cobra (President of the Board) alongside a physician-dominated Administrative Council with regional directors for São Paulo, Rio de Janeiro, and the Federal District. Patient-facing marketing relies on a multilingual corporate website (Portuguese, English, Spanish), LinkedIn and Instagram channels, press coverage, and educational e-books on conditions such as Lupus and Multiple Sclerosis.

Name

Imuno Brasil

Legal name

Imuno Brasil

Website

https://imunobrasil.com.br

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Imuno Brasil is a São Paulo-headquartered, privately held Brazilian medical group delivering multidisciplinary care for immune-mediated diseases across rheumatology, neurology, gastroenterology, dermatology, and immunology, via 150+ specialists across 33+ locations in 5 states, serving 30,000+ patients monthly.

Ownership category

akta.pro rank

Product category

Specialty Healthcare Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Inflammatory Bowel Disease (IBD) Care (HLAKAEAD)

Keywords

• Specialty medical services
• Immune-mediated disease care
• Rheumatology neurology gastroenterology
• Multidisciplinary physician network
• Hospital and clinic care

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Healthcare Services: Imuno Brasil generates revenue through medical consultation and treatment services provided across its network of hospitals and clinics. The company operates in the supplementary health system (health insurance) and provides care for patients with immune-mediated diseases in multiple specialties.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Imuno Brasil is a healthcare services company providing multidisciplinary medical care for patients with immune-mediated diseases across five specialties: rheumatology, neurology, gastroenterology, dermatology, and immunology. Care is delivered through 150+ specialist physicians across 33+ hospitals, clinics, and offices in 5 Brazilian states, and the company supplements its clinical services with scientific research and patient-facing educational publications such as e-books on Multiple Sclerosis and Lupus. The company generates revenue through medical consultations and treatments provided under the supplementary health system and private pay arrangements.

Product overview

Imuno Brasil is a healthcare services company offering medical care for patients with immune-mediated diseases across five specialties: Rheumatology, Neurology, Gastroenterology, Dermatology, and Immunology. The company operates as a unified medical group rather than a software product platform. Its portfolio includes core clinical services delivered through a network of 150+ specialist physicians across 33+ service locations in Brazil, supplemented by educational publications (e-books) covering specific conditions like Multiple Sclerosis and Lupus. The company evolved from Cobra Reumatologia, extending its expertise from rheumatology to multiple immune-mediated disease specialties.

Differentiator

Problem solved

Functional benefit

Products and services

• Rheumatology Services Treatment of immune-mediated rheumatic diseases (DRIM), including autoimmune conditions affecting joints, muscles, eyes, skin, lungs, kidneys, brain, and peripheral nerves. The core service line inherited from the predecessor Cobra Reumatologia.
• Neurology Services Treatment of immune-mediated inflammatory diseases of the nervous system including Multiple Sclerosis, Optic Neuromyelitis, MOG antibody disease, Myasthenia gravis, Chronic Inflammatory Demyelinating Polyneuropathy, and Chronic Migraines.
• Gastroenterology Services Specialized treatment of Inflammatory Bowel Diseases (IBD), including Ulcerative Colitis and Crohn's Disease, characterized by chronic inflammation of the gastrointestinal tract.
• Dermatology Services Treatment of immune-mediated skin diseases such as psoriasis, chronic urticaria, and hidradenitis suppurativa, with interface to rheumatology for diseases with cutaneous manifestations.
• Immunology Services Medical services dedicated to studying and treating diseases related to the immune system, complementing the multidisciplinary approach to immune-mediated diseases.
• E-book: Esclerose Múltipla (Multiple Sclerosis) Educational e-book organized by neurologist Dr. Renata Faria Simm, providing essential information about Multiple Sclerosis for patients, caregivers, and others seeking to understand the condition.
• E-book: Lupus First volume of Imuno Brasil's e-book collection, prepared by rheumatologist Dr. Marília Ambiel Dagostin Furquim, covering all aspects of Lupus, its symptoms, manifestations, and treatment options.

Quantifiable outcome

• Over 30,000 patients treated monthly across all specialties
• +3 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• Hospital Santa PaulacoreStrategic or Co-development Partner · 1 March 2021Medical team partnership with Hospital Santa Paula for clinical care and COVID-19 research. The partnership resulted in the publication of research on seroconversion in rheumatic patients and includes coordination of the Neurology Department.
• Department of Rheumatology and Immunology at University Erlangen-Nuremberg (Germany)coreStrategic or Co-development PartnerImuno Brasil has a research partnership with the Department of Rheumatology and Immunology at the University Erlangen-Nuremberg in Germany. This partnership enables access to cutting-edge medical research and international collaboration in rheumatology and immunology.
• McCaig Institute for Bone and Joint Health, University of CalgarycoreStrategic or Co-development PartnerImuno Brasil has a partnership with the McCaig Institute for Bone and Joint Health at the University of Calgary in Canada. This collaboration supports research in musculoskeletal and joint health areas.
• KPMO Cultura e ArteminorOthersKPMO Cultura e Arte serves as the editorial partner for Imuno Brasil's e-book collection covering diseases in all specialties. They handle the editorial coordination and art direction for publications.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Grupo Fleury: Major Brazilian diagnostics and integrated healthcare services company operating across multiple states. While more diagnostics-focused, it provides outpatient specialty services in adjacent areas and competes for the same patient pool in the supplementary health system.
• Hospital Moinhos de Vento: Major Brazilian private hospital based in Porto Alegre with strong multi-specialty coverage including rheumatology and neurology. Competes with Imuno Brasil for complex patient referrals, particularly in southern Brazil.
• Hospital Sírio-Libanês: Leading Brazilian private hospital network offering multi-specialty care with strong reputations in rheumatology, neurology, and gastroenterology. Overlaps significantly with Imuno Brasil's specialty mix and physician recruitment pool, but operates as a full-service hospital rather than a specialist group.
• Hospital Israelita Albert Einstein: One of Brazil's largest private hospital networks with comprehensive specialty care including rheumatology, neurology, gastroenterology, and dermatology. Competes for the same specialist physicians and complex patient referrals but operates at much greater scale and breadth than Imuno Brasil.
• Rede D'Or São Luiz: Largest private hospital network in Brazil with national presence and broad specialty coverage. Overlaps with Imuno Brasil in rheumatology, neurology, and gastroenterology, with significantly greater scale and capital resources.
• Dasa: Brazil's largest diagnostics and outpatient healthcare company. While primarily a diagnostics chain, Dasa operates specialty clinics and competes in the same outpatient, supplementary-health ecosystem as Imuno Brasil.

Direct peers

• A.C. Camargo Cancer Center: Brazilian specialty medical center focused on oncology with a deep specialist physician model and active research partnerships. Similar institutional structure to Imuno Brasil as a single-specialty-dominant specialist group with academic affiliations.
• Grupo Oncoclínicas: Brazilian specialty medical group operating a multi-site, multi-state network of specialist physicians focused on oncology. Same specialty group model as Imuno Brasil (federated specialist network, hospital partnerships, branded care lines), but focused on oncology rather than immune-mediated diseases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/imunobrasil
• Instagraminstagram.com/imuno.brasil

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Imuno Brasil